Pharmacists should advocate for clinical trial designs that employ remote monitoring and require fewer on-site visits to better ensure diverse participation in those trials. Furthermore, healthcare providers should be non-emotional and thoughtful about how they use electronic health record (EHR) notes, and refrain from referring to a patient—especially from marginalized populations—as “difficult” or “nonadherent.”
These were among the